Microvascular rarefaction and tissue vascular resistance in hypertension
- PMID: 2912175
- DOI: 10.1152/ajpheart.1989.256.1.H126
Microvascular rarefaction and tissue vascular resistance in hypertension
Abstract
The purpose of this study was to quantitatively estimate the relative contribution of arteriolar rarefaction (disappearance of microvessels) and arteriolar constriction to the increases in total peripheral resistance and changes in the patterns of flow distribution observed in hypertension. A mathematical model of the hamster cheek pouch intraluminal microcirculation was constructed based on data from the literature and observations from our own laboratory. Separate rarefaction and constriction of third-order (3A) and fourth-order (4A) arterioles were performed on the model, and the results were quantified based on the changes of the computed vascular resistance. The degree of increase in resistance depended both on the number and the order of vessels rarefied or constricted and also on the position of those vessels in the network. The maximum increases in resistance obtained in the model runs were 21% for rarefaction and 75% for constriction. Rarefaction, but not constriction, produced large increases in the degree of heterogeneity of blood flow in the various vessel orders. These results demonstrate that vessel rarefaction significantly influences tissue blood flow resistance to a degree comparable with vessel constriction; however, unlike constriction, microvascular rarefaction markedly altered blood flow distribution in our model of the hamster cheek pouch vascular bed. These findings conform with the hypothesis that a significant component of the increase in total peripheral resistance in hypertension may be due to vessel rarefaction.
Similar articles
-
Arteriolar and capillary remodelling in hypertension.Drugs. 1999;58 Spec No 1:37-40. Drugs. 1999. PMID: 10526957 Review.
-
Microcirculation and arterial hypertension.Drugs. 1999;58 Spec No 1:1-10. Drugs. 1999. PMID: 10526952 Review.
-
Microcirculation and arterial hypertension.Drugs. 1999;59 Spec No:1-10. Drugs. 1999. PMID: 10548386 Review.
-
The microcirculation and hypertension.J Hypertens Suppl. 1992 Dec;10(7):S147-56. J Hypertens Suppl. 1992. PMID: 1291649 Review.
-
Circumferential wall stress as a mechanism for arteriolar rarefaction and proliferation in a network model.Microvasc Res. 1994 Mar;47(2):188-202. doi: 10.1006/mvre.1994.1015. Microvasc Res. 1994. PMID: 8022319
Cited by
-
The Mechanobiology of Vascular Remodeling in the Aging Lung.Physiology (Bethesda). 2022 Jan 1;37(1):28-38. doi: 10.1152/physiol.00019.2021. Epub 2021 Sep 13. Physiology (Bethesda). 2022. PMID: 34514871 Free PMC article. Review.
-
Race and hypertension. What is clinically relevant?Drugs. 1994 Jun;47(6):914-32. doi: 10.2165/00003495-199447060-00005. Drugs. 1994. PMID: 7521831 Review.
-
Effect of low thyroid function on cardiac structure and function in spontaneously hypertensive heart failure rats.J Card Fail. 2008 Mar;14(2):167-71. doi: 10.1016/j.cardfail.2007.10.018. J Card Fail. 2008. PMID: 18325465 Free PMC article.
-
Hypertension toxicity of VEGFR-TKIs in cancer treatment: incidence, mechanisms, and management strategies.Arch Toxicol. 2025 Jan;99(1):67-81. doi: 10.1007/s00204-024-03874-4. Epub 2024 Sep 30. Arch Toxicol. 2025. PMID: 39347999 Review.
-
Computational Network Model Prediction of Hemodynamic Alterations Due to Arteriolar Rarefaction and Estimation of Skeletal Muscle Perfusion in Peripheral Arterial Disease.Microcirculation. 2015 Jul;22(5):360-9. doi: 10.1111/micc.12203. Microcirculation. 2015. PMID: 25866235 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical